(Press-News.org) UNDER STRICT EMBARGO UNTIL 10AM (UK TIME) ON MONDAY 5 FEBRUARY 2024
Researchers from Queen Mary University of London have found that the molecule RvT4 enhances the body’s natural defences against atherosclerosis (hardening of the arteries) in patients with rheumatoid arthritis.
Studies in mice undertaken by researchers from Queen Mary University of London’s William Harvey Research Institute and Centre for Inflammation and Therapeutic Innovation, and funded by the European Research Council (ERC) and Barts Charity, shows that increasing levels of the RvT4 molecule in the body improves the ability of the body’s own defence mechanisms [macrophages] to reduce local inflammation and remove blockages in blood vessels. This breakthrough in understanding the processes involved could lead to better treatments for people who have rheumatoid arthritis (RA), and who are at higher risk of developing cardiovascular disease.
Rheumatoid arthritis (RA) is the most common form of inflammatory arthritis in the UK and affects around 1% of the population. Approximately 10,000 people receive a diagnosis of RA every year. Alongside the more widely-known symptoms of joint inflammation, people with the condition are also twice as likely as others to develop blood vessel disease. This can lead to serious complications and an increased risk of premature death.
One type of blood vessel disease seen in people with RA is atherosclerosis, which is caused by a build-up of fatty material called ‘plaque’ along the artery walls. This build-up causes the arteries to harden and narrow, making it more difficult to circulate blood around the body. These blockages can also break free, causing heart attacks and strokes. Understanding the reasons why RA patients are at increased risk of these cardiovascular problems is critical in developing better treatments for this group and others.
To gain a better understanding of the causes of blood vessel disease in patients with RA, researchers explored the role of a group of molecules called 13-series resolvins (RvTs). In experimental arthritis the levels of one of these molecules, RvT4, are markedly reduced, a phenomenon that associates with a higher degree of blood vessel disease. This study was designed to explore why this might be the case.
The findings
The study found that treating arthritic mice with RvT4 reduced blood vessel inflammation by re-programming macrophages - a group of white blood cells that accumulate in the diseased vessels - to release stored lipids. Researchers observed that these lipids were preventing the macrophage from carrying out their usual work of clearing dead cells and reducing localised inflammation in blood vessels. Once freed of their lipid burden, the macrophages were able to move and work much more effectively to reduce the causes of atherosclerosis. The observation that RvT4 restores protective macrophage biological activities is an exciting finding.
RA patients also often present with metabolic dysfunction and this is thought to exacerbate vascular disease. The study found that administration of RvT4 to mice engineered to develop characteristics of metabolic dysfunction, advanced atherosclerosis, and arthritis led to an overall decrease in lipoprotein-associated cholesterol in plasma and an increase in the ratio of HDL-associated cholesterol to total cholesterol.
Jesmond Dalli, Professor in Molecular Pharmacology and Lipid Mediator Unit Director at the William Harvey Institute, Queen Mary University of London, said: “The study is important because it identifies for the first time the loss of RvT4 production as a potential new cause of blood vessel inflammation in the context of arthritis, offering a mechanistic explanation on the cause of this important disease in RA patients. It also showed that RvT4 restores the biological activities of lipid loaded macrophages by promoting lipid breakdown and efflux from the cells, an observation that can guide the development of new treatments to limit the incidence and/or severity of cardiovascular disease in patients with RA.”
Victoria King, Director of Funding and Impact at Barts Charity said: “This exciting new discovery helps to explain why certain patients with rheumatoid arthritis are more likely to develop blood vessel disease. This could pave the way for the development of new treatments for these patients to help them live longer and healthier lives.”
Dysregulation of macrophage biological responses by lipid accumulation is also involved in the onset and development of many other conditions, including obesity. Medicines derived from RvT4 or RvT4-based compounds may therefore be useful to limit inflammation and promote the release of accumulated lipids out of macrophages in patients with a number of other medical conditions.
ENDS
NOTES TO EDITORS
Contact:
Honey Lucas
Faculty Communications Officer – Medicine and Dentistry
Queen Mary University of London
Email: h.lucas@qmul.ac.uk or press@qmul.ac.uk
Paper details:
The published paper: “Resolvin T4 enhances macrophage cholesterol efflux to reduce vascular disease”.
Journal: Nature Communications
Publication date and embargo: Embargoed until 10.00 am (UK time) on Monday 5 February 2024
DOI: 10.1038/s41467-024-44868-1
Available after publication at: https://www.nature.com/articles/s41467-024-44868-1
Funding information: This work was supported by funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant no: 677542) and Barts Charity (grant no: MGU0343 and MGU0439). J.D. is also supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant 107613/Z/15/Z).
About Queen Mary
www.qmul.ac.uk
At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable.
Throughout our history, we’ve fostered social justice and improved lives through academic excellence. And we continue to live and breathe this spirit today, not because it’s simply ‘the right thing to do’ but for what it helps us achieve and the intellectual brilliance it delivers.
Our reformer heritage informs our conviction that great ideas can and should come from anywhere. It’s an approach that has brought results across the globe, from the communities of east London to the favelas of Rio de Janeiro.
We continue to embrace diversity of thought and opinion in everything we do, in the belief that when views collide, disciplines interact, and perspectives intersect, truly original thought takes form.
About Barts Charity
As East London’s oldest healthcare charity, we’ve been at the forefront of advancing healthcare for hundreds of years. The hospitals we support provide excellent care to their patients. Yet too many people’s lives in East London are affected by ill health. At Barts Charity we have East London in our hearts and we want healthier, longer lives for everyone in our community.
As the dedicated charity for Barts Health NHS Trust, we support St Bartholomew’s, Whipps Cross, Newham, Royal London, and Mile End hospitals, as well as the Faculty of Medicine and Dentistry at Queen Mary University of London. We also support researchers at the School of Health & Psychological Sciences at City, University of London. Visit https://www.bartscharity.org.uk
About the European Research Council (ERC)
The European Research Council, set up by the EU in 2007, is the premier European funding organisation for excellent frontier research. It funds creative researchers of any nationality and age, to run projects based across Europe.
END
Study finds new treatment to reverse inflammation and arterial blockages in rheumatoid arthritis
2024-02-05
ELSE PRESS RELEASES FROM THIS DATE:
Improving climate predictions by unlocking the secrets of soil microbes
2024-02-05
Climate models are essential to predicting and addressing climate change, but can fail to adequately represent soil microbes, a critical player in ecosystem soil carbon sequestration that affects the global carbon cycle. A team of scientists led by the Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) has developed a new model that incorporates genetic information from microbes. This new model enables the scientists to better understand how certain soil microbes efficiently store carbon supplied by plant ...
City of Hope preclinical study uncovers two proteins’ crucial role in causing cancer cell growth
2024-02-05
FINDINGS
Scientists at City of Hope®, one of the largest cancer research and treatment organizations in the United States, have discovered a new cellular mechanism that plays an important role in cancer cells’ ability to cause disease. The study was published in Nature Structural & Molecular Biology today.
A team led by Chun-Wei (David) Chen, Ph.D., an associate professor of systems biology at City of Hope, pinpointed two cell-surface proteins, integrin αV and β5, that partner to spur cancer cell growth. The researchers next identified a region of integrin αV called the β-propeller domain ...
Immune response, not acute viral infections, responsible for neurological damage, McMaster researchers discover
2024-02-05
For years, there has been a long-held belief that acute viral infections like Zika or COVID-19 are directly responsible for neurological damage, but researchers from McMaster University have now discovered that it’s the immune system’s response that is behind it.
The research, published on Feb. 5, 2024 in Nature Communications, was led by Elizabeth Balint, a PhD student at McMaster, and Ali Ashkar, a professor with the Department of Medicine and the Canada Research Chair in Natural Immunity and NK Cell Function.
“We were interested in trying to ...
Scientists mix and match properties to make new superconductor with chiral structure
2024-02-03
Tokyo, Japan – Researchers from Tokyo Metropolitan University have created a new superconductor with a chiral crystalline structure by mixing two materials, one with superconductivity but no chirality, another with chirality but no superconductivity. The new platinum-iridium-zirconium compound transitions to a bulk superconductor below 2.2 K and was observed to have chiral crystalline structure using X-ray diffraction. Their new solid solution approach promises to accelerate the discovery and understanding of ...
Cary Institute receives NSF funding to offer ecological research experiences for teachers
2024-02-03
(Millbrook, NY) Cary Institute for Ecosystem Studies is launching a new program to support high school and middle school educators in teaching global change and ecology. Starting in the summer of 2024, nine teachers will spend six weeks at Cary Institute conducting collaborative research in ecosystem science. Follow-up meetings throughout the school year will support the teachers as they develop and implement innovative curricula based on their research experiences.
The program is funded by a three-year award from the National Science Foundation as part of its Research ...
California voter poll: Schiff leads, while Porter and Garvey neck-and-neck for second in the U.S. Senate primary
2024-02-03
U.S. Rep. Katie Porter and former Los Angeles Dodger Steve Garvey are deadlocked in the race for second place in the U.S. Senate primary in California, according to a new poll on California politics and policies from USC; California State University, Long Beach; and Cal Poly Pomona.
U.S. Rep. Adam Schiff, a Democrat, leads all candidates with 25% of likely voters, according to the California Elections and Policy Poll. Porter, a Democrat, and Garvey, a Republican, each received support from 15%. Other candidates are in single digits, with Democratic U.S. Rep. ...
Researchers identify protein linked to metastasis in pancreatic cancer
2024-02-03
Pancreatic cancer is the No. 3 cause of cancer-related deaths in the United States, and only 12% of patients survive five years after being diagnosed. Severe pancreatic cancer is associated with metastasis, and it is this spread of secondary tumors that usually causes death, but little is known about the molecular mechanisms that drive metastasis.
In a study published Dec. 18 in Advanced Science, researchers from the University of California, Davis showed that abnormal expression of the protein Engrailed-1 (EN1) ...
Common food preservative has unexpected effects on the gut microbiome
2024-02-02
Food manufacturers often add preservatives to food products to keep them fresh. A primary purpose of these preservatives is to kill microbes that could break down and otherwise spoil the food. Common additives like sugar, salt, vinegar and alcohol have been used as preservatives for centuries, but modern-day food labels now reveal more unfamiliar ingredients such as sodium benzoate, calcium propionate, and potassium sorbate.
Bacteria produce chemicals called bacteriocins to kill microbial competitors. These chemicals can serve as natural preservatives by killing potentially dangerous pathogens ...
Single-port robotic surgery is making its debut in the mountain west
2024-02-02
Huntsman Cancer Institute at the University of Utah (the U) proudly introduces the first and only single-port robot in the Mountain West for head and neck surgical oncology patients. This state-of-the-art technology is a groundbreaking step in the field of oncological surgery, allowing for greater precision and less invasive procedures. Under the visionary leadership of dedicated healthcare professionals, the institute is committed to revolutionizing treatments for cancer patients.
“I am delighted that Huntsman Cancer Institute can now offer cancer patients in the Mountain West access to this innovative and life-changing technology,” says Sachin ...
Potential to ‘save more lives than doctors’: Rice launches WaTER Institute to develop accessible clean water technology
2024-02-02
Forty-three million Americans lack access to municipal water, and 1 in 10 people globally do not have access to safe drinking water. Rice University’s new WaTER Institute, launched today, aims to address this and other complex water-related challenges.
“Clean water can save more lives than doctors,” said Pedro J. Alvarez , the institute’s director and the George R. Brown Professor of Civil and Environmental Engineering.
The institute’s researchers will also predict and prevent diseases by monitoring wastewater; ...